TAVI vs Open Valve Surgery in India: Which Is Right for You in 2026?
Your cardiologist mentioned TAVI — a new valve through a catheter, no open-chest surgery. It sounds straightforward. Sometimes it genuinely is. Sometimes open surgery remains the better long-term choice, particularly if you are under 65 with a 25-year life expectancy and the TAVI durability data only extends 5–10 years. This guide explains both procedures, what the trials actually showed, the durability question nobody explains clearly, and who should choose which — including why Fortis Escorts, who performed the first TAVI in India, is the right place to have both options evaluated.
By Gaf Healthcare Editorial Team
2026-05-19
TAVI vs Open Valve Surgery in India: Which Is Right for You in 2026?
Your cardiologist has told you that your aortic valve needs to be replaced. Then came a word you were not expecting — TAVI. Or maybe TAVR, which is the same procedure with a different acronym depending on which country wrote the report. No open-chest surgery. A new valve delivered through a catheter from your groin. You went home and started reading, and now you are trying to figure out whether this is actually as straightforward as it sounds — and whether it is right for you specifically.
The honest answer is: sometimes yes, sometimes no. TAVI is one of the most significant advances in cardiac medicine in the last 20 years.
It has genuinely changed the lives of patients who previously had no surgical option. It is also being used in patients for whom open surgery remains the better long-term choice — partly because TAVI is newer and more interesting, partly because the financial incentives in catheterisation laboratories are not always aligned with the patient's 20-year outcome.
This guide explains both procedures honestly — what TAVI involves, what open valve surgery involves, what the evidence shows about long-term durability, who is genuinely better served by each, and why Fortis Escorts Heart Institute — the first hospital in India to perform TAVI — is the right place to have either procedure evaluated.
- 1What TAVI actually involves — the catheter approach
- 2What open valve replacement actually involves
- 3What the evidence shows — the key trials read honestly
- 4The durability question — what nobody knows yet about TAVI in younger patients
- 5Who should have TAVI — and who should not
- 6TAVI cost in India vs open surgery — 2026 figures
- 7Fortis Escorts — why the first TAVI in India matters
- 8Questions to ask before you choose either procedure
For patients who are elderly, frail, or too high-risk for open surgery — TAVI is better. No sternotomy, no bypass machine, faster recovery, equivalent short-to-medium-term survival. For patients under 65 who are fit for surgery and have a long life expectancy — open valve surgery is better. Surgical valves last 20–25+ years. TAVI valves have a proven track record of only 5–10 years, and what happens at year 15 in a 55-year-old who had TAVI is genuinely unknown.
In India, TAVI costs USD 12,000–18,000 and open valve replacement costs USD 8,000–12,000 including the valve device. Fortis Escorts Heart Institute was the first hospital in India to perform TAVI and has the deepest TAVI experience of any Indian centre.
What TAVI Actually Involves — The Catheter Approach
TAVI stands for Transcatheter Aortic Valve Implantation. TAVR — Transcatheter Aortic Valve Replacement — is the same procedure, just the American naming convention. They mean the same thing.
The procedure works like this. A collapsed bioprosthetic valve — made of bovine or porcine pericardium, mounted on a metal frame — is loaded onto the tip of a catheter.
The cardiologist threads that catheter from your femoral artery in your groin, up through the aorta, and into position across your diseased aortic valve. The valve is then deployed — expanded using a balloon, or self-expanding depending on the device — pressing the old diseased valve leaflets outward and taking over the job of controlling blood flow out of the left ventricle.
Your chest is never opened, your breastbone is never cut, and the heart is never stopped. The procedure takes 1–2 hours, and most patients are walking the following day and home within 3–5 days.
For the right patient, this is extraordinary. An 80-year-old with severe aortic stenosis and chronic lung disease who would not survive the physiological stress of open-heart surgery under general anaesthesia can have a new functional valve delivered through their femoral artery and go home to their family within a week. TAVI has extended life and improved quality of life for patients who previously had no option.
The access route is usually the femoral artery in the groin. When that route is not suitable — because of peripheral vascular disease or small vessel size — alternative approaches include transapical (through a small incision in the chest wall directly to the heart apex) or subclavian (through the artery under the collarbone). These alternative routes are less comfortable and carry somewhat higher risk.
TAVI replaces only the aortic valve. It cannot simultaneously address coronary artery disease — if you also have significant coronary blockages, those will need to be treated separately, either before the TAVI or during the same session.
It cannot currently replace a mitral valve in the same way — mitral TAVI exists but is much less established than aortic TAVI. And it leaves the old diseased valve leaflets in place, pressed against the aortic wall, which has implications for future re-interventions.
What Open Valve Replacement Actually Involves
Open aortic valve replacement involves a median sternotomy — the breastbone is divided with a saw from top to bottom. The heart is stopped using cardioplegia solution, and the bypass machine takes over circulation. The surgeon removes the diseased aortic valve completely — cuts out the calcified leaflets, debrides the valve ring — and sews in a prosthetic valve, either tissue (bioprosthetic) or mechanical.
The procedure takes 2–4 hours depending on complexity. The hospital stay is 7–10 days. Recovery takes 6–8 weeks before returning to normal activity — the sternum needs that time to heal solidly before it can bear the stresses of daily movement.
What open surgery offers that TAVI currently cannot is complete removal of the diseased valve and anatomically perfect seating of the prosthesis. The surgeon has direct vision of the valve ring.
They can debride calcium. They can size the prosthesis precisely to the anatomy.
They can address concurrent coronary disease at the same time. The long-term track record of surgical valves — both tissue and mechanical — extends to 25+ years in published registries.
For a fit 58-year-old with isolated aortic stenosis and a 30-year life expectancy, open surgery with a tissue valve gives them one operation, a valve that has 20+ years of documented durability, and the option of a straightforward TAVI into the surgical valve ring if they ever need re-intervention decades from now — a procedure called valve-in-valve TAVI.
What the Evidence Shows — The Key Trials Read Honestly
The clinical evidence for TAVI comes primarily from a series of randomised trials that compared TAVI to open surgery across different risk groups. Reading them honestly — not as a TAVI advocate or a surgical advocate — produces a picture that is more nuanced than the headlines suggest.
PARTNER 1 (2011) — high-risk patients
The original PARTNER trial compared TAVI to open surgery in high-risk patients — those with a Society of Thoracic Surgeons (STS) predicted mortality of 10% or above. At one year, all-cause mortality was similar between TAVI and surgery.
TAVI had higher rates of stroke and vascular complications at 30 days. Surgery had higher rates of major bleeding and new atrial fibrillation.
The conclusion was clear: for high-risk patients, TAVI was a reasonable alternative to open surgery with similar survival outcomes. This established TAVI as standard care for high-risk aortic stenosis.
PARTNER 2 and SURTAVI (2016) — intermediate-risk patients
PARTNER 2 and the SURTAVI trial extended TAVI to intermediate-risk patients — STS scores of 4–8%. Both trials found non-inferiority of TAVI compared to surgery at two years. TAVI expanded into the intermediate-risk category based on these results.
The important caveat: these trials followed patients for two years. Two years is not 15 years.
The patients in these trials are now being followed longer, and the durability data is beginning to accumulate. We will return to this below.
PARTNER 3 and EVOLUT LOW RISK (2019) — low-risk patients
The most recent expansion of TAVI into lower-risk, younger patients came from PARTNER 3 and the EVOLUT LOW RISK trial. Both found that TAVI was non-inferior to surgery at one and two years in terms of the composite outcome of death, stroke, and rehospitalisation.
On the strength of these results, guidelines have expanded TAVI eligibility to most patients with severe aortic stenosis, regardless of age or surgical risk. This is the change that has made TAVI available to younger patients — and it is where the honest uncertainty about long-term durability becomes clinically important.
| Trial | Risk group | Follow-up | Finding |
|---|---|---|---|
| PARTNER 1B | Inoperable | 5 years | TAVI dramatically superior to medical therapy alone. Established TAVI for inoperable patients. |
| PARTNER 1A | High risk | 5 years | Similar survival TAVI vs surgery. Structural valve deterioration emerging at 5 years in TAVI arm. |
| PARTNER 2 | Intermediate | 2 years | TAVI non-inferior to surgery. Short follow-up limits durability conclusions. |
| PARTNER 3 | Low risk | 2 years | TAVI superior to surgery at 2 years (lower stroke, rehospitalisation). 5-year data showing convergence of outcomes. |
| EVOLUT LOW RISK | Low risk | 2 years | TAVI non-inferior to surgery at 2 years. Self-expanding valve. 5-year follow-up ongoing. |
The Durability Question — What Nobody Knows Yet About TAVI in Younger Patients
This is the most important section of this guide. It is the section that most TAVI advocates are uncomfortable with, and the section that most patients asking about TAVI do not get explained clearly.
TAVI has been performed in humans since 2002. That means the oldest TAVI valves in patients have been in place for roughly 22 years — but only in the very earliest cases, and those patients were high-risk elderly patients who were not expected to survive for 15+ years anyway.
The large-scale trials in lower-risk patients have follow-up data of 2–5 years. For a 58-year-old patient who has a life expectancy of 25+ more years, 5-year follow-up data tells you almost nothing about what the valve will be doing in year 15 or year 20.
What we do know is that the PARTNER 1A trial — the longest-running large TAVI trial — showed evidence of structural valve deterioration beginning to emerge at 5 years in the TAVI arm, at rates not seen with surgical valves at the same timepoint. This is not definitive evidence of widespread failure. It is a signal that warrants very careful attention as the longer-term data matures.
The honest position is this: for a 75-year-old with a life expectancy of 10–12 years, TAVI valve durability is probably not the decisive issue — the patient is unlikely to outlive the valve. For a 55-year-old with a life expectancy of 25+ years, whether the TAVI valve will still be functioning well at year 20 is genuinely unknown. Surgical tissue valves have 25-year registry data. TAVI valves do not.
If a surgical tissue valve fails after 15–20 years, the most common re-treatment is now TAVI into the existing surgical valve ring — valve-in-valve TAVI. This is a well-established procedure with good outcomes. A younger patient who has open valve surgery now can expect that if they ever need re-intervention, valve-in-valve TAVI will likely be available to them without another open operation.
If a TAVI valve fails, re-intervention is technically more difficult. The old TAVI frame is still in place. A second TAVI into a failed TAVI is possible but carries higher risk of coronary obstruction and is anatomically more constrained. Open surgery to remove a failed TAVI is a very complex operation. This asymmetry in re-intervention options is one of the reasons cardiac surgeons remain cautious about TAVI in younger patients.
Who Should Have TAVI — and Who Should Not
TAVI is strongly preferred for patients who are 75 and older, frail, or too high-risk for open surgery due to lung disease, kidney disease, prior chest surgery, or other significant comorbidities. Open surgery is generally preferred for patients under 65 who are fit for surgery, because of the 20-year durability data advantage of surgical valves. Ages 65–75 require individual assessment based on anatomy, fitness, and the patient's own values around recovery speed versus long-term valve durability.
| Patient profile | Preferred approach | Reason |
|---|---|---|
| 75+ and frail or high-risk | TAVI strongly preferred | Open surgery risk too high. TAVI provides survival and quality-of-life benefit without surgical risk. Durability adequate for expected lifespan. |
| 70–75, good health, suitable anatomy | TAVI reasonable | Shorter recovery time. 15+ year durability less critical at this age. Anatomy must support transfemoral access. |
| 65–70 — grey zone | Individual assessment essential | Durability uncertainty significant over 20+ years. Heart team discussion required. Patient preferences around re-operation risk matter. |
| Under 65, fit for surgery | Open surgery preferred | 25+ year life expectancy. Surgical valve durability data extends 20–25 years. TAVI durability at 15+ years unknown. Re-intervention options better with surgical valve. |
| Any age — unsuitable femoral anatomy | Alternative approach or open | Non-transfemoral TAVI (transapical, subclavian) carries higher procedural risk. Open surgery may be preferable depending on overall risk profile. |
| Concurrent coronary disease requiring CABG | Open surgery strongly preferred | Open surgery allows valve replacement and bypass grafting in a single session. TAVI cannot simultaneously address coronary disease in the same way. |
TAVI Cost in India vs Open Surgery — 2026 Figures
TAVI costs more than open valve surgery in India, as it does everywhere. The TAVI valve device itself — the Edwards SAPIEN 3, Medtronic EVOLUT, or equivalent — is expensive regardless of which country it is used in. The device accounts for a large part of the total procedure cost.
| Procedure | India (USD) | USA (USD) | Hospital stay |
|---|---|---|---|
| TAVI (transfemoral, device included) | USD 12,000–18,000 | USD 80,000–150,000 | 3–5 days |
| Open aortic valve replacement (tissue valve, device included) | USD 8,000–12,000 | USD 80,000–150,000 | 8–12 days |
| Open aortic valve replacement (mechanical valve, device included) | USD 9,000–13,000 | USD 90,000–160,000 | 8–12 days |
| Valve-in-valve TAVI (into prior surgical valve) | USD 11,000–16,000 | USD 70,000–130,000 | 3–5 days |
| TAVI + CABG (valve and bypass, combined) | USD 16,000–24,000 | USD 150,000–300,000 | 10–14 days |
India's price advantage on TAVI — paying USD 12,000–18,000 versus USD 80,000–150,000 in the USA — is primarily due to lower hospital operational costs. The valve devices themselves are priced similarly internationally; India does not access significantly cheaper devices. The saving comes from the same structural factors that make bypass surgery cheaper: lower physician salaries, lower real estate, lower administrative overhead.
The recovery time advantage of TAVI — 3–5 days in hospital versus 8–12 for open surgery — also translates into lower accommodation costs during your India stay. A TAVI patient typically needs 2–3 weeks near the hospital before flying home.
An open valve patient needs 5–6 weeks. For international patients, this difference in India stay is itself a significant cost and logistical factor.
Fortis Escorts — Why the First TAVI in India Matters
Fortis Escorts Heart Institute performed the first TAVI in India. This is not a marketing claim — it is a verifiable historical fact about which institution led the introduction of this technique in the country. What it means practically is that Fortis Escorts has been performing TAVI longer than any other Indian hospital, has managed more TAVI complications, and has accumulated more case experience with the procedure than any other centre in India.
TAVI is a procedure where volume matters enormously. The most dangerous complications — coronary artery obstruction during valve deployment, severe paravalvular leak, complete heart block requiring pacemaker — require immediate recognition and management. A team that has seen these complications before, multiple times, reacts differently to them than a team encountering them for the first time.
Fortis Escorts also performs the full range of valve procedures for international patients — TAVI, open tissue valve replacement, open mechanical valve replacement, valve repair, and valve-in-valve TAVI.
A patient who comes for evaluation can have both options genuinely assessed by a team with deep expertise in both. This matters because the right procedure for you should be chosen by comparing both options properly, not by going to a centre that only does one.
First in India for TAVI · 80,000+ CABG · JCI · NABH · 175+ countries served
Questions to Ask Before You Choose Either Procedure
These are the specific questions that will cut through the institutional enthusiasm for whichever procedure a given centre performs most frequently.
-
1
"What is my STS score — and what does it mean for my surgical risk?"
The Society of Thoracic Surgeons predicted mortality score is the standard measure of open surgery risk. An STS score below 4% is low risk. Above 8% is high risk. Your score should be part of the TAVI versus open discussion. Ask for the number.
-
2
"If I have TAVI now and it fails in 15 years, what are my options for re-intervention?"
The answer to this question changes based on your anatomy, your age at that future point, and the state of TAVI technology in 15 years. Ask the physician to walk through the realistic re-intervention pathways. A complete answer to this question requires honesty about what is currently unknown.
-
3
"How many TAVI procedures has the specific operator who would perform mine done personally?"
For TAVI, operator volume is as critical as hospital volume. An operator who has performed 300+ TAVI procedures manages complications differently to one who has done 50. Ask for the specific number for the cardiologist who will actually hold the catheter.
-
4
"Has a cardiac surgeon also reviewed my case — not just the interventional cardiologist?"
Guidelines require a heart team discussion for TAVI candidacy. A cardiac surgeon's view of whether open surgery is a viable and preferable option should be part of the process. If only the interventional cardiologist has assessed you, the evaluation is incomplete.
TAVI, open valve, bypass — all procedures itemised vs USA and UK
Which hospital for TAVI and which for open valve — honest assessment
Tissue vs mechanical, device costs, INR monitoring, total trip costs
Visa, flights, total trip costs — your country's complete guide
TAVI or open surgery — get the right answer for your anatomy.
Send your echocardiogram, CT scan, and cardiac history to GAF Healthcare. Within 48 hours the team at Fortis Escorts — who performed the first TAVI in India — will review your case and tell you specifically which procedure is right for you and why. Free. No obligation to travel.
Sources: Smith CR et al. PARTNER 1 Trial, NEJM 2011 · Leon MB et al. PARTNER 2 Trial, NEJM 2016 · Reardon MJ et al. SURTAVI Trial, NEJM 2017 · Mack MJ et al. PARTNER 3 Trial, NEJM 2019 · Popma JJ et al. EVOLUT LOW RISK Trial, NEJM 2019 · 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization · ESC/EACTS Guidelines on Myocardial Revascularization 2023 · Fortis Escorts Heart Institute TAVI programme data 2026 · GAF Healthcare Hospital Review Database 2026